Claudia Fritz

Suggest Changes
Learn More
BACKGROUND There is insufficient evidence for the long-term efficacy and safety of anti-tumour necrosis factor therapy in patients with ankylosing spondylitis (AS). This is the first report on the(More)
  • 1